PTSD Evaluation & Medication Management

PTSD Evaluation & Medication Management at KwikPsych

Accurate diagnosis is the foundation of effective PTSD treatment. At KwikPsych, Dr. Monika Thangada conducts comprehensive psychiatric evaluations using validated screening tools, evidence-based assessment protocols, and clinical expertise to:

• Confirm PTSD diagnosis and rule out related conditions
• Assess severity and symptom profile
• Identify comorbid mental health and medical conditions
• Develop tailored medication management strategies
• Coordinate therapy recommendations
• Provide ongoing medication monitoring and optimization

A thorough evaluation ensures you receive the right diagnosis and begin the right treatment—avoiding months of ineffective care.

Why Comprehensive PTSD Evaluation Matters

Many people with trauma symptoms receive incorrect diagnoses:

• Generalized anxiety when the symptoms are actually trauma-specific hyperarousal
• Depression when anhedonia and guilt are trauma-related rather than primary mood disorder
• ADHD when concentration problems stem from intrusive trauma memories
• Personality issues when emotional dysregulation reflects trauma's impact on nervous system regulation

Additionally, trauma survivors often have comorbid conditions that require integrated treatment:

• Major depression (present in ~50% of PTSD cases)
• Anxiety disorders (panic, social anxiety, specific phobias)
• Substance use disorder (self-medication for trauma symptoms)
• Traumatic brain injury (TBI)
• Sleep disorders
• Chronic pain

Proper evaluation identifies all these factors, preventing fragmented care and ensuring comprehensive treatment.

Dr. Monika Thangada's PTSD Evaluation Process

Step 1: Initial Psychiatric Consultation (60-90 minutes)

Your first appointment with Dr. Thangada is comprehensive and trauma-informed:

Chief Complaint and Current Symptoms

• What brings you in today?
• Timeline of current symptoms (when did they start?)
• Severity and functional impact (work, relationships, daily activities)

Detailed Trauma History (conducted with trauma-informed care)

• What traumatic event(s) are you experiencing symptoms from?
• When did the trauma occur?
• Relationship to the traumatic event (direct exposure, witness, family member, first responder, etc.)
• Life-threat perception and actual danger level
• Ongoing trauma-related concerns (legal cases, unresolved grief, etc.)

Current PTSD Symptom Assessment

• Intrusive symptoms: Flashbacks, nightmares, intrusive memories, emotional/physical reactivity
• Avoidance: What situations, people, places, thoughts, or feelings are you avoiding?
• Negative cognition and mood: Changes in self-perception, trust, world-view; persistent guilt or shame
• Arousal and reactivity: Sleep disruption, irritability, hypervigilance, concentration problems, startle response

Psychiatric History

• Prior mental health diagnoses
• Previous therapy or treatment and outcomes
• Family history of mental illness
• Current mood and anxiety symptoms beyond trauma

Medical History and Medications

• Current medical conditions
• Current medications and supplements
• Previous surgeries or hospitalizations
• History of head injury or traumatic brain injury (TBI)
• Substance use history and current use

Suicide and Safety Assessment

• Suicidal thoughts, plans, or attempts
• Self-harm behaviors
• Substance use as coping mechanism
• Access to means
• Current support system

Functional Assessment

• Work/school performance and attendance
• Relationship quality and stability
• Social engagement and isolation
• Self-care and daily functioning
• Ability to handle responsibilities

Step 2: Standardized Screening and Assessment Instruments

Dr. Thangada uses validated, evidence-based assessment tools that directly map to diagnostic criteria:

PCL-5 (PTSD Checklist for DSM-5)

A 20-item self-report questionnaire directly aligned with DSM-5-TR PTSD diagnostic criteria.

Structure:

• 4 items assess intrusion symptoms
• 2 items assess avoidance
• 7 items assess negative changes in cognition and mood
• 6 items assess arousal and reactivity
• 1 item assesses functional impact

Scoring:

• Total score ranges 0-80
• Score ≥31 suggests probable PTSD
• Score ≥38 is consistent with PTSD diagnosis
• Repeated PCL-5 throughout treatment tracks progress (goal: score <11)

Advantages:

• Quick to complete (5-10 minutes)
• Highly sensitive and specific for PTSD
• Excellent for monitoring treatment response
• Used across VA, military, and civilian settings

CAPS-5 (Clinician-Administered PTSD Scale for DSM-5)

The gold-standard structured diagnostic interview for PTSD.

Structure:

• 30-item clinician-administered interview
• 8 symptom severity items
• Behavioral observation during interview
• Assessment of symptom frequency and intensity
• Functional impact rating
• Onset and duration determination

What It Assesses:

• Detailed exploration of each of the four PTSD symptom clusters
• Symptom onset date (critical for distinguishing acute vs. chronic vs. delayed-onset PTSD)
• Functional impairment specifically attributable to PTSD
• Differential diagnosis considerations

Advantages:

• Gold standard for PTSD diagnosis in clinical trials and research
• Comprehensive symptom probing
• Captures nuances missed by self-report alone
• Establishes definitively whether PTSD diagnostic criteria are met
• Allows assessment of delayed-onset PTSD

Timeline: 45-90 minutes (can be done over multiple visits if needed)

PHQ-9 (Patient Health Questionnaire-9)

Screens for major depression and mood symptom severity.

Why It Matters:

• Major depression is comorbid in ~50-80% of PTSD cases
• Depressive symptoms (guilt, anhedonia, concentration, sleep) overlap with PTSD
• Helps differentiate primary depression from trauma-related mood changes
• PHQ-9 score guides antidepressant selection and dosing

Scoring:

• Total score 0-27
• 5-9: mild depression
• 10-14: moderate depression
• 15-19: moderately severe depression
• 20-27: severe depression
• Goal in treatment: score <5

GAD-7 (Generalized Anxiety Disorder-7)

Screens for generalized anxiety and related anxiety disorders.

Why It Matters:

• Distinguishes generalized anxiety from trauma-specific hyperarousal
• Identifies panic disorder or social anxiety co-occurring with PTSD
• Guides medication selection (some SSRIs work better for both PTSD and GAD)

Scoring:

• Total score 0-21
• 5-9: mild anxiety
• 10-14: moderate anxiety
• 15-21: severe anxiety
• Goal: score <5

Step 3: Differential Diagnosis

Not all trauma responses are PTSD. Dr. Thangada distinguishes PTSD from related conditions:

Acute Stress Disorder (ASD)

Occurs in first 3 days to 1 month after trauma; shares PTSD symptoms but shorter duration. If symptoms persist beyond 1 month, diagnosis becomes PTSD.

Adjustment Disorder

Distress from identifiable stressor but symptoms don't meet PTSD criteria (less severe, less specific to trauma, more reactive to general life stress).

Complex Grief (Complicated Bereavement)

Intense grief following loss that doesn't include flashbacks or full PTSD symptomatology; doesn't meet trauma or shock criterion.

Acute Stress (Normal Post-Trauma Reaction)

Intense fear/distress in first days/weeks after trauma that naturally resolves (most people recover without intervention).

Dissociative Disorders

Extreme dissociation, fragmented identity, or lost time suggest dissociative disorder rather than primary PTSD (though dissociation can accompany PTSD).

Substance-Induced Symptoms

Withdrawal from alcohol or benzodiazepines mimics hyperarousal; stimulant use causes hypervigilance; assessment clarifies if symptoms are substance-related vs. PTSD.

Clinical Pearl: One person can have PTSD plus another condition (e.g., PTSD + major depression + panic disorder), which requires integrated treatment.

Step 4: Assessment for Comorbid Conditions

Trauma survivors frequently develop accompanying mental health conditions requiring treatment:

Screening Includes:

• Substance use disorder: Current substance use, history of dependence, use as coping mechanism
• Major depression: Pervasive sadness, anhedonia, hopelessness, suicidality
• Panic disorder: Unexpected panic attacks, fear of panic
• Social anxiety: Fear of social situations and evaluation
• Specific phobias: Intense fear of trauma-related situations (driving, crowds, etc.)
• Obsessive-compulsive disorder: Intrusive thoughts/images, compulsive behaviors (related to trauma)
• Borderline personality disorder: Emotion dysregulation, relationship instability, self-harm (especially from childhood trauma)
• Traumatic brain injury: Loss of consciousness, post-concussive symptoms, cognitive complaints

Step 5: Medical Evaluation

PTSD has biological underpinnings affecting multiple body systems:

Medical History Review:

• Sleep apnea (worsens hyperarousal; requires treatment)
• Thyroid dysfunction (causes anxiety symptoms)
• Chronic pain conditions (often comorbid with PTSD)
• Cardiovascular disease (trauma increases cardiac risk)
• Diabetes and metabolic conditions
• Neurological conditions
• Prior head injuries or TBI

Medication Review:

• Current medications and their psychiatric effects
• Drug-drug interactions with planned PTSD medications
• Allergies and adverse reactions

Physical Examination:

• Vital signs (blood pressure, heart rate often elevated in PTSD)
• General health assessment
• Blood pressure monitoring (important if starting venlafaxine)

Labs (when indicated):

• Thyroid function (TSH)
• Complete metabolic panel (baseline for medications)
• Other labs based on medical history

Medication Management for PTSD

Once evaluation confirms PTSD diagnosis and identifies comorbid conditions, Dr. Thangada develops your personalized medication strategy.

Goals of PTSD Medication

Medication targets specific symptom clusters to:

• Reduce intrusive thoughts and nightmares
• Lower hyperarousal and hypervigilance
• Improve sleep quality
• Treat comorbid depression or anxiety
• Enhance capacity to engage in trauma-focused therapy
• Restore quality of life

Medications should enhance therapy, not replace it. Research clearly shows combined psychotherapy + medication is superior to medication alone.

FDA-Approved PTSD Medications

Sertraline (Zoloft)

• Drug class: SSRI (selective serotonin reuptake inhibitor)
• Dosing: Start 50 mg daily; titrate to 50-200 mg daily (typical: 100-150 mg)
• Timeline: Initial benefit 2-4 weeks; full benefit 8-12 weeks
• Benefits: Reduces intrusive memories, emotional numbing, hyperarousal; effective for comorbid depression and anxiety
• Side effects: Generally well-tolerated; initial activation (usually resolves), sexual dysfunction (less common), sleep disruption initially (usually improves)
• Advantages: Long safety record, well-studied in PTSD, effective, usually affordable
• Disadvantages: Takes several weeks for full effect; sexual side effects possible

Paroxetine (Paxil)

• Drug class: SSRI
• Dosing: Start 10-20 mg daily; titrate to 20-60 mg daily (typical: 40 mg)
• Timeline: Initial benefit 2-4 weeks; full benefit 8-12 weeks
• Benefits: Excellent for anxiety symptoms; effective for PTSD and comorbid anxiety disorders
• Side effects: Sedation (can be beneficial for sleep), weight gain possible, sexual dysfunction possible
• Advantages: Often sedating (helpful for sleep); strong evidence for PTSD
• Disadvantages: Weight gain risk, withdrawal effects if discontinued, may be sedating for some

Other Highly Effective PTSD Medications

Venlafaxine XR (Effexor XR)

• Drug class: SNRI (serotonin-norepinephrine reuptake inhibitor)
• Dosing: Start 37.5-75 mg daily; titrate to 150-375 mg daily (typical: 225-300 mg)
• Timeline: Initial benefit 2-3 weeks; full benefit 6-8 weeks
• Benefits: Excellent for PTSD, particularly if comorbid anxiety/depression present; activating (good for anhedonia/numbness)
• Side effects: Activation (tremor, anxiety initially), blood pressure elevation (requires monitoring), sexual dysfunction, sleep disruption
• Monitoring: Blood pressure checks at baseline and during titration
• Advantages: Strong evidence for PTSD; good for emotional numbing
• Disadvantages: Requires blood pressure monitoring; activating side effects; withdrawal if discontinued

Prazosin

• Drug class: Alpha-1 adrenergic antagonist (originally for blood pressure)
• Dosing: Start 1 mg at bedtime; titrate to 4-20 mg nightly (typical: 8-15 mg)
• Timeline: Nightmare improvement 1-2 weeks; full benefit 4 weeks
• Benefits: Reduces nightmares and night terrors; improves sleep quality; non-addictive; non-controlled
• Side effects: Minimal; occasional dizziness (take at bedtime), rarely low blood pressure
• Monitoring: Blood pressure; usually safe even with low starting BP
• Advantages: Specifically targets nightmares; minimal side effects; non-addictive; inexpensive
• Disadvantages: Sometimes less effective for daytime symptoms; may require multiple doses if dosing daytime

Clinical Use: Often combined with SSRI—SSRI for overall PTSD symptoms, prazosin for nightmares.

Mirtazapine (Remeron)

• Drug class: Tetracyclic antidepressant
• Dosing: Start 15 mg at bedtime; titrate to 15-45 mg daily (typical: 30 mg at night)
• Timeline: Sleep improvement 1-3 nights; mood benefit 2-4 weeks
• Benefits: Excellent for sleep initiation and quality; improves appetite; increases weight
• Side effects: Sedation (desired if dosed at night), weight gain, metabolic effects possible
• Advantages: Excellent for sleep; helps appetite/weight if underweight; can be used as monotherapy or adjunct
• Disadvantages: Weight gain (potential problem if overweight); sedation (desired if timed correctly)

Other Medications Used for PTSD

Topiramate (Topamax)

• Off-label but evidence-based for PTSD
• Particularly helpful for impulsivity and emotional dysregulation
• Requires monitoring for cognitive side effects and kidney stones
• Typical dose: 100-400 mg daily

Guanfacine (Intuniv)

• Alpha-2 agonist
• Helpful for hyperarousal, impulsivity, sleep
• Similar timeline and monitoring to prazosin

Valproate (Depakote)

• Mood stabilizer with some evidence for PTSD
• Particularly complex PTSD or severe irritability
• Requires blood monitoring

Medication Selection: Tailored to Your Symptom Profile

Dr. Thangada's medication recommendations depend on your specific symptoms:

Predominantly Intrusive Symptoms (Flashbacks, Nightmares)?

→ Sertraline or Paroxetine + Prazosin

Severe Emotional Numbing and Avoidance?

→ Venlafaxine (activating) or Sertraline

Severe Sleep Disruption and Nightmares?

→ Mirtazapine + SSRI, or Prazosin + SSRI

Comorbid Depression?

→ Sertraline, Paroxetine, Mirtazapine, or Venlafaxine

Comorbid Anxiety?

→ Sertraline, Paroxetine, or Venlafaxine

Complex PTSD with Emotion Dysregulation?

→ Venlafaxine + Prazosin; consider mood stabilizer

Medication Trial and Optimization

Week 1-2: Medication initiated at low dose; you monitor for initial side effects and benefit

Week 2-4: Gradual dosage increase toward therapeutic range while monitoring effects

Week 4-8: Assessment of treatment response; if inadequate benefit, consider dose increase or medication change

Week 8-12: Full treatment response typically evident; medication stabilization

Week 12+: Maintenance dosing; periodic monitoring appointments

If First Medication Ineffective:

• Optimize dosage before switching
• Consider combination therapy (SSRI + prazosin)
• Try different medication class
• Ensure medication adherence and therapy engagement
• Assess for drug-drug interactions or medical factors

Expected Timeline: It typically takes 2-4 medication trials over 3-4 months to find optimal fit.

Ongoing Medication Management

Monitoring Appointments

Dr. Thangada provides:

• Initial titration visits: Weekly or bi-weekly during first month to assess tolerance and efficacy
• Ongoing monitoring: Monthly during active treatment; quarterly during maintenance
• Symptom assessment: Regular PCL-5, PHQ-9, GAD-7 to track objective progress
• Side effect monitoring: Blood pressure (for venlafaxine), weight (for mirtazapine), sexual function, sleep quality
• Therapeutic collaboration: Regular communication with your therapist about medication impact on therapy engagement

Medication Stability and Maintenance

• Most people remain on PTSD medication 12+ months after achieving remission
• Discontinuation should be gradual (over weeks to months) to prevent withdrawal effects
• Some people benefit from long-term maintenance medication
• Relapse prevention planning discusses medication continuation strategies

Medication Adjustments

As trauma symptoms improve, medication may be:

• Continued at same dose: If working well
• Optimized: Slight dose adjustment if side effects develop
• Gradually tapered: Once sustained remission achieved (typically after 12 months)
• Adjusted for life changes: Job stress, new relationships, anniversaries often require temporary increases

Insurance, Costs, and Scheduling

Accepted Insurance

In-network with 10+ major carriers:

• Aetna
• Blue Cross Blue Shield (BCBS)
• Cigna
• UnitedHealthcare
• Superior HealthPlan/Ambetter
• Baylor Scott & White
• Oscar
• First Health Network
• Optum
• Medicare

Insurance typically covers psychiatric evaluation and medication management.

Self-Pay Rates

• Initial psychiatric evaluation: $299
• Follow-up med management visits: $179 each

Telehealth

All evaluation and medication management available via secure video throughout Texas.

Scheduling

Call 737-367-1230 to schedule comprehensive PTSD evaluation with Dr. Thangada. We typically have availability within 1-2 weeks.

FAQs About PTSD Evaluation and Medication

Q: How long does a comprehensive PTSD evaluation take?

A: Initial evaluation is 60-90 minutes. If CAPS-5 is administered, add 45-90 minutes. Most people complete evaluation in one appointment; some prefer two visits.

Q: Will I be diagnosed in one appointment?

A: Usually yes. Dr. Thangada can confirm PTSD diagnosis based on clinical interview and PCL-5. CAPS-5 provides definitive diagnostic confirmation if needed.

Q: Do I need brain imaging (fMRI, SPECT) for PTSD diagnosis?

A: No. PTSD is diagnosed clinically based on symptom criteria, not brain imaging. Imaging is not standard or necessary for diagnosis.

Q: How do I know which medication to start?

A: Dr. Thangada's recommendation is based on your specific symptom profile, medical history, previous medication trials, and comorbid conditions. Sertraline or paroxetine are usual first-line choices due to strong evidence and tolerability.

Q: What if medication doesn't work?

A: Many factors affect medication response. Dr. Thangada may: increase dosage, switch medications, add a second medication, or assess for barriers (non-adherence, insufficient therapy engagement, ongoing stress). It's usually a process of optimization.

Q: Are PTSD medications addictive?

A: No. SSRIs, SNRIs, prazosin, and mirtazapine are not addictive and have no abuse potential. Some people experience withdrawal if discontinued too rapidly (symptoms resolve with gradual tapering), but this is not addiction.

Q: Can I take PTSD medication while doing therapy?

A: Yes—and this is optimal. Medication helps stabilize symptoms so you can engage more effectively in trauma-focused therapy. They work synergistically.

Q: How long will I be on medication?

A: Typically 12-24 months minimum. Some people benefit from longer-term or lifelong medication. Discontinuation is gradual and planned with Dr. Thangada's guidance.

Q: Is telehealth medication management as safe as in-person?

A: Yes. For ongoing medication management, telehealth is safe and equally effective. Initial evaluation can be in-person or telehealth; medication management visits can all be via secure video.

Q: What if I want therapy without medication?

A: Therapy alone is effective for PTSD, especially with trauma-focused modalities. However, if you have moderate-to-severe symptoms, comorbid depression, or sleep disruption, medication enhances therapy response and accelerates improvement.

Crisis Support

If you or someone you know is in crisis, call 911 or the Suicide & Crisis Lifeline at 988, or text HOME to 741741 (Crisis Text Line).

Schedule Your PTSD Evaluation Today

Accurate diagnosis and personalized medication management are the foundation of effective PTSD treatment. Dr. Monika Thangada provides comprehensive evaluation and evidence-based medication strategies to help you recover.

Contact KwikPsych:

• Phone: 737-367-1230
• Address: 12335 Hymeadow Dr, Suite 450, Austin, TX 78750
• Telehealth: Available throughout Texas

Related Resources

• Understanding PTSD: Complete Condition Guide
• Comprehensive PTSD Treatment
• PTSD Therapy: Evidence-Based Modalities
• PTSD Testing & Assessment
• National Center for PTSD - Assessment